SLC40A1 and diabetes mellitus: The results obtained from this study showed for the first time that V administered at the dose of 1 mg V/day as bis(maltolato)oxovanadium(IV) to diabetic rats reduces the expression level of hepcidin, increases the expression level of ferroportin, and improves the anemic state caused by diabetes.